DayTwo’s $37 Million Financing

Naschitz Brandes Amir advised DayTwo.

DayTwo closed a $37 million financing round to continue development of technologies and solutions designed to improve the health of people with diabetes and other metabolic diseases.

DayTwo is a leading Israeli precision medicine company.

The Naschitz Brandes Amir team included partners Noga Devecseri Spira (Picture), Assif Rosenberg and associate Noa Nitzan.

Involved fees earner: Noga Devecseri Spira – Naschitz Brandes Amir; Noa Nitzan – Naschitz Brandes Amir; Assif Rosenberg – Naschitz Brandes Amir;

Law Firms: Naschitz Brandes Amir;

Clients: DayTwo ;

Leave a Reply